Redcare Pharmacy Inkomsten in het verleden
Verleden criteriumcontroles 0/6
Redcare Pharmacy's earnings have been declining at an average annual rate of -3.2%, while the Consumer Retailing industry saw earnings growing at 9.5% annually. Revenues have been growing at an average rate of 21.8% per year.
Belangrijke informatie
-3.2%
Groei van de winst
6.5%
Groei van de winst per aandeel
| Consumer Retailing Groei van de industrie | 10.5% |
| Inkomstengroei | 21.8% |
| Rendement op eigen vermogen | -1.9% |
| Nettomarge | -0.4% |
| Volgende winstupdate | 05 Nov 2024 |
Recente prestatie-updates uit het verleden
Recent updates
Is There Now An Opportunity In Redcare Pharmacy NV (ETR:RDC)?
Apr 21
Are Investors Undervaluing Redcare Pharmacy NV (ETR:RDC) By 26%?
Apr 07Investors Interested In Redcare Pharmacy NV's (ETR:RDC) Revenues
Mar 25Redcare Pharmacy (ETR:RDC) Is Carrying A Fair Bit Of Debt
Feb 13Why Investors Shouldn't Be Surprised By Redcare Pharmacy NV's (ETR:RDC) P/S
Dec 24Is There An Opportunity With Redcare Pharmacy NV's (ETR:RDC) 48% Undervaluation?
Dec 06Is Redcare Pharmacy (ETR:RDC) Using Too Much Debt?
Sep 07Why Redcare Pharmacy NV (ETR:RDC) Could Be Worth Watching
Aug 02Why We're Not Concerned About Redcare Pharmacy NV's (ETR:RDC) Share Price
Jul 17Broker Revenue Forecasts For Shop Apotheke Europe N.V. (ETR:SAE) Are Surging Higher
May 28Here's Why Shop Apotheke Europe (ETR:SAE) Can Afford Some Debt
May 11We Think Shop Apotheke Europe (ETR:SAE) Has A Fair Chunk Of Debt
Jan 10Is Shop Apotheke Europe (ETR:SAE) Using Too Much Debt?
Sep 25Is Shop Apotheke Europe (ETR:SAE) Weighed On By Its Debt Load?
Jun 08Is Shop Apotheke Europe (ETR:SAE) Using Too Much Debt?
Feb 28Here's Why Shop Apotheke Europe (ETR:SAE) Has A Meaningful Debt Burden
Aug 01Shop Apotheke Europe N.V.'s (ETR:SAE) About To Shift From Loss To Profit
May 11Shop Apotheke Europe (ETR:SAE) Has A Somewhat Strained Balance Sheet
Apr 14Insider Buying: The Shop Apotheke Europe N.V. (ETR:SAE) Chairman of the Managing Board & CEO Just Bought €96k Worth Of Shares
Mar 14Opbrengsten en kosten
Hoe Redcare Pharmacy geld verdient en uitgeeft. Gebaseerd op laatst gerapporteerde winst, op LTM-basis.
Inkomsten en omzetgeschiedenis
| Datum | Inkomsten | Inkomsten | G+A Uitgaven | R&D-uitgaven |
|---|---|---|---|---|
| 30 Jun 24 | 2,128 | -9 | 501 | 0 |
| 31 Mar 24 | 1,987 | -10 | 473 | 0 |
| 31 Dec 23 | 1,799 | -12 | 444 | 0 |
| 30 Sep 23 | 1,595 | -16 | 419 | 0 |
| 30 Jun 23 | 1,404 | -45 | 392 | 0 |
| 31 Mar 23 | 1,272 | -65 | 393 | 0 |
| 31 Dec 22 | 1,204 | -78 | 379 | 0 |
| 30 Sep 22 | 1,165 | -110 | 368 | 0 |
| 30 Jun 22 | 1,118 | -105 | 359 | 0 |
| 31 Mar 22 | 1,081 | -91 | 320 | 0 |
| 31 Dec 21 | 1,060 | -74 | 299 | 0 |
| 30 Sep 21 | 1,037 | -39 | 277 | 0 |
| 30 Jun 21 | 1,038 | -29 | 256 | 0 |
| 31 Mar 21 | 1,020 | -18 | 238 | 0 |
| 31 Dec 20 | 968 | -17 | 214 | 0 |
| 30 Sep 20 | 895 | -15 | 194 | 0 |
| 30 Jun 20 | 827 | -20 | 182 | 0 |
| 31 Mar 20 | 758 | -27 | 169 | 0 |
| 31 Dec 19 | 701 | -36 | 166 | 0 |
| 30 Sep 19 | 660 | -41 | 162 | 0 |
| 30 Jun 19 | 621 | -40 | 151 | 0 |
| 31 Mar 19 | 584 | -40 | 142 | 0 |
| 31 Dec 18 | 540 | -34 | 127 | 0 |
| 30 Sep 18 | 481 | -31 | 116 | 0 |
| 30 Jun 18 | 415 | -28 | 104 | 0 |
| 31 Mar 18 | 351 | -24 | 92 | 0 |
| 31 Dec 17 | 284 | -21 | 80 | 0 |
| 30 Sep 17 | 244 | -22 | 70 | 0 |
| 30 Jun 17 | 222 | -20 | 63 | 0 |
| 31 Mar 17 | 200 | -20 | 57 | 0 |
| 31 Dec 16 | 177 | -18 | 50 | 0 |
| 30 Sep 16 | 159 | -13 | 45 | 0 |
| 30 Jun 16 | 147 | -13 | 43 | 0 |
| 31 Mar 16 | 136 | -12 | 40 | 0 |
| 31 Dec 15 | 126 | -11 | 36 | 0 |
| 31 Dec 14 | 85 | -5 | 23 | 0 |
| 31 Dec 13 | 55 | -3 | 15 | 0 |
Kwaliteitswinsten: RDC is currently unprofitable.
Groeiende winstmarge: RDC is currently unprofitable.
Analyse vrije kasstroom versus winst
Analyse van de winstgroei in het verleden
Winsttrend: RDC is unprofitable, and losses have increased over the past 5 years at a rate of 3.2% per year.
Versnelling van de groei: Unable to compare RDC's earnings growth over the past year to its 5-year average as it is currently unprofitable
Winst versus industrie: RDC is unprofitable, making it difficult to compare its past year earnings growth to the Consumer Retailing industry (8.5%).
Rendement op eigen vermogen
Hoge ROE: RDC has a negative Return on Equity (-1.91%), as it is currently unprofitable.